Report cover image

Ophthalmic Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Publisher GlobalData
Published Dec 13, 2022
Length 45 Pages
SKU # GBDT17643610

Description

Ophthalmic Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Ophthalmic Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Ophthalmic Imaging Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Ophthalmic Imaging equipment is used to create images to aid in the diagnosis and treatment of eye diseases.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Ophthalmic Imaging Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ophthalmic Imaging Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ophthalmic Imaging Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

45 Pages
  • About GlobalData
    • Ophthalmic Imaging Equipment Overview
    • Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
    • Ophthalmic Imaging Equipment - Pipeline Products by Territory
    • Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
    • Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date
    • Ophthalmic Imaging Equipment Companies - Companies Pipeline Products by Stage of Development
    • Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
    • Advanced Medical Electronics Corp Company Overview
    • Ai-Ris LLC Company Overview
    • Columbia University Company Overview
    • IDCP Scotland Ltd Company Overview
    • JuneBrain, LLC Company Overview
    • L.V. Prasad Eye Institute Company Overview
    • Physical Sciences Inc Company Overview
    • Spring Vision Ltd Company Overview
    • TeleMedC Pte Ltd Company Overview
    • University of South Florida Company Overview
    • Oct 27, 2022: Molecular Partners Announces Planned Departure of Chief Financial Officer
    • Oct 04, 2022: Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2
    • Sep 30, 2022: Remidio Inc to launch Instaref R20, a handheld portable auto refractometer, at the American Academy of Ophthalmology 2022
    • Sep 26, 2022: Bausch & Lomb Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting
    • Aug 04, 2022: Optomed's financial reporting in 2023
    • Jul 22, 2022: Xisi Guo leaves Optomed's Board of Directors
    • Jul 20, 2022: Gland Pharma announces Unaudited Financial Results For The Quarter Ended June 30, 2022
    • Jul 18, 2022: Carl Zeiss Meditec and Precise Bio announce partnership in the development and commercialization of tissue-based implants for ophthalmology
    • Jul 13, 2022: Pioneering device can take 3D images to detect eye diseases
    • Jul 12, 2022: Aspire & USF Pass $10M in ticket & donation revenue
    • Jun 23, 2022: Bausch + Lomb Announces Brett Icahn and Gary Hu Have Been Appointed to its Board of Directors
    • Jun 08, 2022: Bausch + Lomb Announces First-Quarter 2022 Results and Provides 2022 Guidance
    • May 25, 2022: Bausch + Lomb Will Release First-Quarter 2022 Financial Results on June 8
    • May 16, 2022: Bausch + Lomb Files Financial Statements for the First Quarter of 2022
    • May 02, 2022: Voxeleron launches iNebula, a cloud-based platform for optimized ophthalmic clinical trial workflow
    • Apr 01, 2022: Brian Coblitz Appointed Executive Director of GW Technology Commercialization Office
    • Mar 17, 2022: Molecular Partners Publishes Invitation to Annual General Meeting 2022
    • Mar 15, 2022: Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021
    • Mar 02, 2022: Voptica Announces the appointment of Francoise Ganet & Joe Sullivan, to its Board of Directors
    • Feb 12, 2022: Molecular Partners to Present at Upcoming Healthcare Investor Conference
    • Jan 21, 2022: Gland Pharma announce statement of unaudited financial results for the quarter and nine months ended december 31, 2021
    • Dec 10, 2021: INIFY Laboratories becomes an independent company
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.